|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.080 USD | 0.00% |
|
-28.92% | -56.22% |
| Market Cap | 25.25M 22.2M 20.68M 19M 35.65M 2.42B 36.13M 245M 95.94M 1.2B 94.78M 92.73M 4.13B | P/E 2026 * |
-0.58x | P/E 2027 * | -0.96x |
|---|---|---|---|---|---|
| Enterprise Value | 1.96M 1.73M 1.61M 1.48M 2.77M 188M 2.81M 19.09M 7.47M 93M 7.38M 7.22M 322M | EV / Sales 2026 * |
0.09x | EV / Sales 2027 * | -51.4x |
| Free-Float |
77.71% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Aligos Therapeutics, Inc.
| 1 week | -28.92% | ||
| Current month | -29.29% | ||
| 1 month | -26.75% | ||
| 3 months | -36.25% | ||
| 6 months | -51.37% | ||
| Current year | -56.22% |
| 1 week | 3.98 |  | 5.8 |
| 1 month | 3.98 | | 7.08 |
| Current year | 3.98 | | 10.49 |
| 1 year | 3.98 | | 13.69 |
| 3 years | 3.76 | | 46.8 |
| 5 years | 3.76 | | 449.25 |
| 10 years | 3.76 | | 937.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lawrence Blatt
CEO | Chief Executive Officer | 64 | 2018-02-04 |
Lesley Calhoun
DFI | Director of Finance/CFO | 60 | 2020-05-31 |
Julian Symons
CTO | Chief Tech/Sci/R&D Officer | 65 | 2018-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2018-07-31 | |
K. Hirth
BRD | Director/Board Member | 74 | 2018-07-31 |
Lawrence Blatt
CHM | Chairman | 64 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/25/26 | Free | Director | 5,860 | 0.1088% | ||
| 6/25/26 | Free | Director | 5,860 | 0.1088% | ||
| 6/25/26 | Free | Director | 5,860 | 0.1088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -28.92% | -55.31% | -81.96% | 25.25M | |
| +2.08% | -1.48% | -1.34% | +14.07% | 46.86B | |
| -0.61% | +1.03% | +396.16% | +643.07% | 40.23B | |
| 0.00% | +4.45% | +11.81% | +60.81% | 36.23B | |
| +2.48% | +3.37% | +7.05% | -8.08% | 34.72B | |
| +0.62% | +1.65% | +5.41% | +43.89% | 27.89B | |
| -2.00% | +9.60% | +31.71% | +129.76% | 16.79B | |
| -0.17% | -2.90% | - | - | 16.74B | |
| +0.78% | -4.78% | -2.68% | +9.96% | 13.12B | |
| +1.82% | -0.72% | -9.75% | -33.31% | 12.7B | |
| Average | +0.50% | -2.02% | +42.56% | +86.47% | 24.53B | |
| Weighted average by Cap. | +0.71% | +1.05% | +74.68% | +138.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.68M 19.06M 17.75M 16.31M 30.61M 2.08B 31.02M 211M 82.37M 1.03B 81.37M 79.62M 3.55B | 5M 4.4M 4.1M 3.76M 7.06M 480M 7.16M 48.59M 19M 237M 18.77M 18.36M 819M |
| Net income | -93.85M -82.54M -76.87M -70.62M -133M -9B -134M -912M -357M -4.44B -352M -345M -15.37B | -124M -109M -102M -93.46M -175M -11.91B -178M -1.21B -472M -5.88B -466M -456M -20.34B |
| Net Debt | -23.28M -20.48M -19.07M -17.52M -32.88M -2.23B -33.32M -226M -88.48M -1.1B -87.4M -85.52M -3.81B | -282M -248M -231M -212M -398M -27.06B -404M -2.74B -1.07B -13.36B -1.06B -1.04B -46.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | US$4.080 | 0.00% | 213,037 |
| 26-07-24 | US$4.080 | -13.01% | 203,098 |
| 26-07-23 | US$4.690 | -8.93% | 147,916 |
| 26-07-22 | US$5.150 | -5.33% | 58,462 |
| 26-07-21 | US$5.440 | +3.03% | 59,163 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALGS Stock
Select your edition
All financial news and data tailored to specific country editions
